Europe Infusion Bags Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report (2026-2035)

Read more about this report - Request a Free Sample

Europe Infusion Bags Market Overview

The Europe Infusion Bags Market comprises a broad range of sterile medical containers used for the intravenous administration of fluids, electrolytes, parenteral nutrition, blood and blood components, dialysis solutions, and injectable medications. The market includes intravenous (IV) solution bags, total parenteral nutrition (TPN) bags, blood bags, dialysis solution bags, specialty infusion bags, and associated fluid delivery systems manufactured using PVC and non-PVC materials. Infusion bags play a vital role in fluid management, drug delivery, nutritional support, and transfusion therapy across hospitals, ambulatory surgical centers, specialty clinics, and home healthcare settings. The market was valued at USD 104.18 Million in 2025, driven by the rising prevalence of chronic diseases requiring intravenous therapy, increasing surgical procedures and hospital admissions, growing demand for home-based infusion care, expanding adoption of DEHP-free and non-PVC infusion bags, supportive healthcare investments across Europe, and continuous advancements in sterile manufacturing technologies, material innovation, and infusion safety systems.

Europe Infusion Bags Market Growth Analysis and Key Influencers

Europe Infusion Bags Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Europe Infusion Bags Market Growth Drivers

Rising Chronic Disease Burden and Expanding Intravenous Care Accelerate Infusion Bag Demand

Europe's growing burden of chronic diseases, ageing demographics, and increasing surgical procedures continue to strengthen demand for infusion bags used in hydration, chemotherapy, parenteral nutrition, dialysis, and biologic administration. As per Pérez-Granda et al., 2025, safe vascular access and intravenous therapy remain central to modern hospital care. Recent product innovation has also reinforced market momentum; in 2025, B. Braun expanded investments in infusion technologies and manufacturing while strengthening its IV solutions portfolio. Stable public healthcare expenditure across Europe and improving capital investment in hospital infrastructure further support procurement despite persistent inflationary pressures.

Europe Infusion Bags Market Restraints

High Regulatory Compliance Costs and Rising Manufacturing Expenses Restrain Market Growth

Stringent European environmental legislation and medical device regulations are increasing compliance costs for infusion bag manufacturers, particularly those transitioning from PVC- and DEHP-containing products toward safer alternatives. According to Germany's Federal Institute for Drugs and Medical Devices (BfArM), 2025, safety actions concerning phthalate-containing medical bags highlight evolving regulatory expectations. Simultaneously, manufacturers must invest in material validation, manufacturing upgrades, and regulatory documentation. Elevated financing costs and persistent raw-material price volatility increase capital expenditure requirements, compressing operating margins despite sustained clinical demand. Additionally, prolonged regulatory approval timelines, increasing quality assurance requirements, and the high costs associated with adopting sustainable materials limit production scalability and delay the commercialization of innovative infusion bag products, particularly among small and medium-sized manufacturers across Europe.

Europe Infusion Bags Market Opportunities

Sustainable Non-PVC Technologies and Home Infusion Expand Long-Term Growth Opportunities

The transition toward environmentally sustainable infusion products and decentralized healthcare presents significant opportunities for European manufacturers. As per B. Braun, 2025, healthcare providers are increasingly adopting IV containers manufactured without DEHP or PVC to improve patient safety and environmental sustainability. Simultaneously, expanding home infusion programs, digital medication management, and biologic therapies are increasing demand for advanced infusion systems. As financing conditions gradually stabilize across Europe, investment in sustainable manufacturing and innovation is expected to attract strategic capital while strengthening long-term industry competitiveness.

Europe Infusion Bags Market Trends

Rapid Transition Toward Non-PVC and DEHP-Free Infusion Bags Emerges as the Defining Market Trend

The most significant trend shaping the Europe infusion bags market is the rapid transition from conventional PVC infusion bags to non-PVC, DEHP-free alternatives, driven by stricter European regulatory expectations, sustainability initiatives, and growing emphasis on patient safety. According to B. Braun, 2025, healthcare providers are increasingly adopting infusion containers manufactured without PVC or DEHP to improve drug compatibility and reduce environmental impact. Product innovation accelerated further during 2025, with manufacturers expanding non-PVC production capacity and advanced multilayer polymer technologies. From a financial perspective, sustained investment in sustainable manufacturing is attracting long-term capital despite elevated financing costs, positioning non-PVC infusion platforms as a premium growth segment across Europe.

Europe Infusion Bags Market Share

Intravenous Fluid Therapy is Likely to Dominate the Europe Infusion Bags Market by Application

Intravenous fluid therapy represents the largest application segment in the Europe infusion bags market owing to its indispensable role in managing dehydration, electrolyte imbalance, perioperative care, sepsis, trauma, oncology, and critical care across hospitals and outpatient settings. As per National Institute for Health and Care Excellence (NICE), 2025, intravenous fluid therapy remains a fundamental component of adult inpatient care, supported by evidence-based clinical guidelines that continue to shape procurement practices across the United Kingdom and Europe. During 2025, B. Braun and Baxter International continued strengthening their intravenous solutions portfolios and manufacturing capabilities to ensure supply resilience amid growing clinical demand. From a macroeconomic perspective, sustained public healthcare investment, ageing populations, and increasing hospital utilization continue to support long-term demand for IV fluid administration despite persistent inflationary pressures on healthcare procurement.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Read more about this report - Request a Free Sample

Europe Infusion Bags Market Analysis by Region

The regions included in the report are United Kingdom, Germany, France, Italy, Spain, and others.

Germany is Likely to Dominate the Europe Infusion Bags Market

Germany dominates the Europe infusion bags market owing to its advanced healthcare infrastructure, strong domestic medical technology manufacturing base, high surgical and hospitalization volumes, and the presence of leading infusion therapy companies including B. Braun and Fresenius Kabi. According to B. Braun Annual Report, 2025, Germany remains the company's largest single-country market and a major global manufacturing hub for infusion therapy products. In 2025, B. Braun continued investing in research, production capacity, and digital healthcare technologies while expanding manufacturing capabilities for infusion and hospital care solutions. Supported by resilient healthcare expenditure, robust industrial investment, and continued modernization of hospitals, Germany remains the primary growth engine for the European infusion bags industry despite broader macroeconomic cost pressures.

Leading Players in the Europe Infusion Bags Market

Europe Infusion Bags Market Segmentation

Key Questions Answered in the Europe Infusion Bags Market Report

• What was the Europe Infusion Bags market value in 2025?
• What is the Europe Infusion Bags market forecast outlook for 2026-2035?
• What are the major factors aiding the Europe Infusion Bags market demand?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major Europe Infusion Bags market trends?
• Which product type is expected to dominate the market segment?
• Which material is projected to lead the market segment?
• Which capacity is anticipated to drive the market segment?
• Which application is likely to dominate the market segment?
• Which end-user is likely to dominate the market segment?
• Which distribution channel is expected to lead the market segment?
• Who are the key players involved in the Europe Infusion Bags market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?